GenEdit

Verified by our team

  • Research
Linkedin Twitter Facebook

GenEdit focuses on overcoming the delivery challenges of genetic medicines using its NanoGalaxy platform, which features a library of non-viral, non-lipid polymer nanoparticles. This technology enables targeted delivery of genetic therapies, aiming to treat diseases with high unmet medical needs through improved therapeutic options.

GenEdit Highlights:

  • GenEdit annual revenue is $2.1M.
  • GenEdit total funding is $67.7M.
  • GenEdit headquartered in South San Francisco, California.
  • GenEdit number of employees is 47.

    • Overview

    • Website: genedit.com
    • Headquarters: South San Francisco, California
    • Employees: 47
    • Founded: 2016
    • Email: park@genedit.com
    • Funding: $67.7M
    • Revenue: $2.1M
    • Valuation: n/a

    Contacts

    Kunwoo Lee

    CEO
    Linkedin
    • Email: ***@genedit.com
    Buy the List to Unlock Contacts

    Similar companies

    Frequently Asked Questions related to GenEdit

    GenEdit is located in South San Francisco, California.
    Yes, GenEdit is a Silicon Valley company.
    GenEdit total funding is 67.7M.
    GenEdit revenue is 2.1M.
    GenEdit’s number of employees is 47.
    GenEdit’s CEO name is Kunwoo Lee.
    GenEdit was founded in 2016.
    GenEdit’s contact email is park@genedit.com.

    Follow Silicon Valley Journals

    Awarded by

    corporate vision magazine

    © Copyright 2022-2024 Silicon Valley Journals. All rights reserved.

    Fundings

    Quick links

    Company

    © Copyright SVJ Media Ltd., 71-75 Shelton Street. Covent Garden. London, GB WC2H 9JQ